SEER
Seer, Inc.NASDAQHealthcare$1.70+0.00%ClosedMarket Cap: $95.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.38
P/S
5.82
EV/EBITDA
-1.13
DCF Value
$-12.02
FCF Yield
-47.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
51.1%
Operating Margin
-470.5%
Net Margin
-444.0%
ROE
-26.0%
ROA
-24.9%
ROIC
-27.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $4.2M | 52.0% | $-17.4M | $-16.0M | $-0.29 | — |
| FY 2025 | $16.6M | 51.1% | $-78.0M | $-73.6M | $-1.28 | — |
| Q3 2025 | $4.1M | 51.2% | $-19.3M | $-18.2M | $-0.32 | — |
| Q2 2025 | $4.1M | 52.1% | $-20.5M | $-19.4M | $-0.33 | — |
| Q1 2025 | $4.2M | 49.0% | $-20.7M | $-19.9M | $-0.34 | — |
| Q4 2024 | $3.9M | 9.3% | $-23.5M | $-21.7M | $-0.35 | — |
| FY 2024 | $13.9M | 49.0% | $-100.1M | $-86.6M | $-1.39 | — |
| Q3 2024 | $3.9M | 46.9% | $-24.3M | $-21.3M | $-0.35 | — |
| Q2 2024 | $3.1M | 7.5% | $-27.1M | $-22.9M | $-0.35 | — |
| Q1 2024 | $3.1M | -4.3% | $-25.2M | $-20.7M | $-0.32 | — |
| Q4 2023 | $4.2M | 41.7% | $-22.2M | $-17.8M | $-0.28 | — |
| FY 2023 | $15.2M | 9.5% | $-104.9M | $-86.3M | $-1.35 | — |